Smartleaf Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.91K Buy
+179
New +$1.79K ﹤0.01% 3052
2025
Q2
– Sell
-330
Closed -$2.21K – 2979
2025
Q1
$2.21K Buy
330
+14
+4% +$124 ﹤0.01% 2446
2024
Q4
$2.32K Sell
316
-133
-30% -$1.05K ﹤0.01% 2494
2024
Q3
$3.38K Buy
449
+11
+3% +$96 ﹤0.01% 2293
2024
Q2
$3.88K Buy
+438
New +$4.2K ﹤0.01% 1926

Other funds holding VIR

Smartleaf Asset Management's VIR Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Vir Biotechnology (VIR) in Q3 2026: 179 shares worth $1.91K. The stake represents ﹤0.01% of the portfolio and ranks #3052 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in VIR as recently as Q1 2025.

Smartleaf Asset Management first reported a position in VIR in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.88K in Q2 2024. 222 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Smartleaf Asset Management held 179 shares of Vir Biotechnology worth $1.91K as of Q3 2026.
  • Vir Biotechnology was a new Smartleaf Asset Management position in Q3 2026.
  • Vir Biotechnology made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3052 holding.
  • Smartleaf Asset Management first reported a position in Vir Biotechnology in Q2 2024 and has held it in 5 quarters since.
  • Smartleaf Asset Management's Vir Biotechnology position peaked at $3.88K in Q2 2024.
  • 222 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.